CYBERDYNE Inc. (JP:7779)
:7779
Want to see JP:7779 full AI Analyst Report?
7779 Stock Chart & Stats
¥216.00
-¥5.00(-2.72%)
At close: 4:00 PM EST
¥216.00
-¥5.00(-2.72%)
Day’s Range― - ―
52-Week Range¥164.00 - ¥420.00
Previous CloseN/A
Volume1.10M
Average Volume (3M)724.97K
Market Cap
¥51.94B
Enterprise Value¥25.80B
Total Cash (Recent Filing)¥8.99B
Total Debt (Recent Filing)¥767.00M
Price to Earnings (P/E)357.5
Beta0.81
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.72
Shares Outstanding137,445,820
10 Day Avg. Volume764,380
30 Day Avg. Volume724,970
Financial Highlights & Ratios
PEG Ratio-2.89
Price to Book (P/B)1.40
Price to Sales (P/S)14.44
P/FCF Ratio305.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥400.00Price Target Upside85.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.03
Revenue Forecast (FY)¥4.72B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthVery low leverage and a sizable equity base give CYBERDYNE durable financial flexibility: less refinancing risk, capacity to fund clinical deployments, R&D and support services, and resilience through reimbursement or adoption cycles. This structural conservatism underpins long-term optionality.
Improved Cash GenerationA return to positive operating and free cash flow in 2026 indicates the business can start internally funding operations and service/support obligations. If sustained, this reduces dependency on external funding and supports steady roll-out and maintenance of HAL systems across clinical customers.
Distinctive Product And Market NicheCYBERDYNE's HAL exoskeleton targets rehabilitation and care — a specialized medical robotics niche with high technical barriers, regulatory hurdles and service requirements. This creates durable competitive advantage via product differentiation, sticky service revenue and long sales cycles that favor incumbents.
Bears Say
Persistent Operating LossesDespite recent net income, the core business still records recurring operating losses and negative EBITDA. This structural unprofitability implies reliance on one-off items or non-operating gains to post net profits, challenging the company’s ability to generate sustainable operating earnings as it scales.
Volatile Cash Flow Track RecordHistorical volatility in operating and free cash flow creates uncertainty for capital allocation, service expansion and clinical support investments. Irregular cash conversion raises execution risk and increases the probability the firm will need external financing in downturns, diluting long-term resilience.
Weak Recent Revenue MomentumA recent decline in revenue after multi-year growth signals possible market saturation, competitive pressure, or slower adoption. Reduced top-line momentum makes it harder to leverage fixed costs, slows margin recovery and could strain the path to sustained profitability absent renewed demand drivers.
CYBERDYNE News
7779 FAQ
What was CYBERDYNE Inc.’s price range in the past 12 months?
CYBERDYNE Inc. lowest stock price was ¥164.00 and its highest was ¥420.00 in the past 12 months.
What is CYBERDYNE Inc.’s market cap?
CYBERDYNE Inc.’s market cap is ¥51.94B.
When is CYBERDYNE Inc.’s upcoming earnings report date?
CYBERDYNE Inc.’s upcoming earnings report date is Aug 19, 2026 which is in 58 days.
How were CYBERDYNE Inc.’s earnings last quarter?
CYBERDYNE Inc. released its earnings results on May 14, 2026. The company reported -¥0.17 earnings per share for the quarter, missing the consensus estimate of N/A by -¥0.17.
Is CYBERDYNE Inc. overvalued?
According to Wall Street analysts CYBERDYNE Inc.’s price is currently Undervalued.
Does CYBERDYNE Inc. pay dividends?
CYBERDYNE Inc. does not currently pay dividends.
What is CYBERDYNE Inc.’s EPS estimate?
CYBERDYNE Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CYBERDYNE Inc. have?
CYBERDYNE Inc. has 137,445,820 shares outstanding.
What happened to CYBERDYNE Inc.’s price movement after its last earnings report?
CYBERDYNE Inc. reported an EPS of -¥0.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.795%.
Which hedge fund is a major shareholder of CYBERDYNE Inc.?
Currently, no hedge funds are holding shares in JP:7779
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CYBERDYNE Inc.
Headquartered in Tsukuba, Japan, and founded in 2004, CYBERDYNE Inc. is dedicated to the ongoing research, development, production, sales, leasing, and maintenance of sophisticated equipment and systems, primarily for the medical and defense sectors within Japan. Their innovative product line features the Hybrid Assistive Limb (HAL), available in medical variants for lower limbs and single joints, as well as non-medical versions designed for lower limbs, single joints, and lumbar support. The company also supplies HAL peripherals, robotic cleaners, and autonomous transport robots for factories, offices, and various other indoor environments. A notable technological offering is Acoustic X, a high-speed light pulse LED array that facilitates real-time photoacoustic imaging. Complementing their hardware, CYBERDYNE provides specialized treatments and programs such as Cybernics Treatment, which utilizes HAL to restore or enhance function for individuals suffering from conditions like spinal cord injuries, strokes, and neuromuscular disorders. They additionally offer HAL FIT and Neuro HALFIT to improve brain-nerve-musculoskeletal and general physical functions, respectively, and MTX Neuro HAL Plus to optimize brain-nerve performance in athletes. Furthermore, the company extends its expertise to critical areas including disaster rescue operations, heavy industrial labor assistance, and contributions to the entertainment industry.
7779 Stock 12 Month Forecast
Average Price Target
¥400.00
▲(85.19% Upside)
Technical Analysis
PHC Holdings Corp.
―
Create Medic Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Koken Ltd.
―
Options Prices
Currently, No data available
---